A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.
PHASE2
This study is a randomized, controlled, open-label, multicenter, seamless P...
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
PHASE2
To improve the survival in patients with microsatellite stable metastatic c...
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
PHASE1
This study is designed to evaluate the efficacy and safety of sintilimab-be...
A Randomized Controlled Trial Evaluating Different Doses of Oral Zinc Supplementation in Combination With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma
PHASE2
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)